European Drug Forecasts to 2024

Text with Title

Evaluate European Drug Forecasts gives you the understanding and time you need to drive better decisions.

Real-world, country level historic product sales and consensus based forecasts. Conduct European market sizing, R&D horizon scanning and price comparison using government and company reported sales data with country level, consensus based product forecasts to 2024. 

Contact Us Download Brochure

European market sizing and assessment

Forecasts for key branded drugs at a European country level – market value of over €100bn in 2024.

Conduct future market assessment by mapping future trends of key marketed drugs and pipeline assets that are expected to launch by 2024. Profile in-line products, identify new products, and measure how they impact key therapy areas.

Contact Us
Fragmented World
Past present future

R&D horizon scanning

Explore the full pipeline of R&D products launching in the European market by 2024 with a total forecast revenue of €30bn.

Compare R&D product performance, mapping uptake trends and drivers across key European markets.

Pricing comparison analysis across countries

Ex-factory pricing data for Germany, France, Italy, England, Poland, Spain and other key markets.

Use price/DDD benchmark to inform your quick assessments of new assets and perform comparative analysis across EU-6 countries.

Download Brochure
Data points
 

Request more information

Evaluate is not a package I can do without... It's an absolute timesaver, and if you're saving time you're saving money.

ANTHONY M, SENIOR DIRECTOR, COMPETITIVE INTELLIGENCE & PROSPECTION, NOVARTIS

Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry.

DR. HIROHISA NAKADA, ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, OTSUKA HOLDINGS